Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer (ARTEST)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04869943 |
|
Recruitment Status :
Terminated
(Business decision)
First Posted : May 3, 2021
Last Update Posted : January 26, 2024
|
Sponsor:
Veru Inc.
Information provided by (Responsible Party):
Veru Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 9, 2024 |
| Actual Study Completion Date : | January 9, 2024 |